Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats.
暂无分享,去创建一个
R. Baxter | R. Clark | B. Carlsson | P. Fielder | D. Mortensen | P. Mallet
[1] W. Daughaday. A Personal History of the Origin of the Somatomedin Hypothesis and Recent Challenges to Its Validity , 2015, Perspectives in biology and medicine.
[2] D. Clemmons,et al. Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.
[3] M. Rechler,et al. A major portion of the 150-kilodalton insulin-like growth factor-binding protein (IGFBP) complex in adult rat serum contains unoccupied, proteolytically nicked IGFBP-3 that binds IGF-II preferentially. , 1995, Endocrinology.
[4] A. Sommer,et al. Biochemical analysis of prostate specific antigen-proteolyzed insulin-like growth factor binding protein-3. , 1994, Growth regulation.
[5] R. Baxter,et al. Regulation of the acid-labile subunit of the insulin-like growth factor complex in cultured rat hepatocytes. , 1994, Endocrinology.
[6] R. Clark,et al. Enhanced body growth in uremic rats treated with IGF-I and growth hormone in combination. , 1994, Kidney international.
[7] R. Baxter. Insulin-like growth factor binding proteins in the human circulation: a review. , 1994, Hormone research.
[8] R. Baxter,et al. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex. , 1994, Endocrinology.
[9] L. Phillips,et al. Coculture of primary rat hepatocytes and nonparenchymal cells permits expression of insulin-like growth factor binding protein-3 in vitro. , 1994, Endocrinology.
[10] R. Baxter,et al. Purification and characterization of the acid-labile subunit of rat serum insulin-like growth factor binding protein complex. , 1994, Endocrinology.
[11] R. Baxter,et al. Bioavailability of insulin-like growth factors (IGFs) in rats determined by the molecular distribution of human IGF-binding protein-3. , 1993, Endocrinology.
[12] K. Alberti,et al. A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. , 1993, The Journal of clinical investigation.
[13] G. Cooney,et al. Effect of human insulin-like growth factor-binding protein-1 on the half-life and action of administered insulin-like growth factor-I in rats. , 1993, The Journal of endocrinology.
[14] R. Baxter,et al. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. , 1993, The Journal of clinical investigation.
[15] D. Clemmons,et al. Determination of the pharmacokinetic profiles of insulin-like growth factor binding proteins-1 and -2 in rats. , 1992, Endocrinology.
[16] A. Hoffman,et al. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans. , 1992, The Journal of clinical endocrinology and metabolism.
[17] F. Talamantes,et al. Characterization of insulin-like growth factor binding proteins (IGFBPs) during gestation in mice: effects of hypophysectomy and an IGFBP-specific serum protease activity. , 1990, Endocrinology.
[18] R. Baxter,et al. Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex. , 1990, The Journal of clinical endocrinology and metabolism.
[19] D. Clemmons,et al. Insulin-like growth factor-I (IGF-I) infusion into hypophysectomized or protein-deprived rats induces specific IGF-binding proteins in serum. , 1989, Endocrinology.
[20] E. Froesch,et al. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. , 1989, Acta endocrinologica.
[21] E. Froesch,et al. Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[22] A. Parlow,et al. Highly improved precision of the hypophysectomized female rat body weight gain bioassay for growth hormone by increased frequency of injections, avoidance of antibody formation, and other simple modifications. , 1987, Endocrinology.
[23] R. Baxter,et al. Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma. , 1986, The Journal of clinical investigation.
[24] M. Binoux,et al. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. , 1986, Analytical biochemistry.
[25] A. Herington,et al. Tissue distribution and regulation of insulin-like growth factor (IGF)-binding protein-3 messenger ribonucleic acid (mRNA) in the rat: comparison with IGF-I mRNA expression. , 1992, Endocrinology.
[26] Janet L. Martin,et al. High Molecular Weight Insulin-like Growth Factor Binding Protein Complex , 1989 .
[27] R. Clark,et al. Recombinant human insulin-like growth factor: testing the somatomedin hypothesis in hypophysectomized rats. , 1987, The Journal of endocrinology.